Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
JCO Global Oncology|August 7, 2026
Evaluating Global Disparities in the Availability of Prostate Cancer Clinical TrialsVitor Abreu de Góes, Miguel Zugman, Koral Shah, et al.
JAMA Network Open|April 29, 2024
Barriers to Clinical Trial Implementation Among Community Care CentersHedyeh Ebrahimi, Sandra Megally, Elana Plotkin, et al.
Journal for Immunotherapy of Cancer|May 5, 2026
Characterization of aberrant alternative splicing landscape in patients with metastatic renal cell carcinomaAmeish Govindarajan, Nathaniel Hansen, Benjamin D Mercier, et al.
Clinical Genitourinary Cancer|August 21, 2025
Clinical and Pathological Predictors for Occult Lymph Node Involvement in Patients With Clinical Node-Negative Bladder Cancer Undergoing Radical CystectomySalvador Jaime-Casas, Miguel Zugman, Regina Barragan-Carrillo, et al.
Frontiers in Oncology|October 23, 2025
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinomaSalvador Jaime-Casas, Regina Barragan-Carrillo, Miguel Zugman, et al.
JCO Precision Oncology|April 10, 2025
Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung CarcinomaSalvador Jaime-Casas, Neal S Chawla, Nicholas J Salgia, et al.
Cancers|October 16, 2025
Clinical Predictors and Prognostic Significance of Pathologic Disease Upstaging at Radical Cystectomy in Patients with Muscle-Invasive Bladder CancerSalvador Jaime-Casas, Wesley Yip, Daniel J Lama, et al.
Lancet (London, England)|September 16, 2024
Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 StudyToni K Choueiri, Laurence Albiges, Philippe Barthélémy, et al.
JCO Precision Oncology|September 24, 2025
Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell TumorsRebecca Hassoun, Reuben Ben-David, John P Sfakianos, et al.
Cancer Medicine|March 27, 2025
Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and InclusionBenjamin D Mercier, Ameish Govindarajan, Daniela V Castro, et al.
Pageof 4